While genome editing tools have been around for decades, most of the credit for this meteoric rise goes to CRISPR-Cas9. Its potential to change the lives of millions of patients around the world has piqued the interest of small and large biotechs as well as that of governmental and private investors.
This report covers the scientific background of the industry’s most common genome editing tools and provides exclusive industry insights by experts in the field. It also takes a look at the evolving genome editing market and addresses the future applications and challenges of genome editing tools.
"*" indicates required fields